While Novartis holds a diversified product portfolio, there is some product concentration with its largest drugs, Entresto (close to 15% of sales) and Cosentyx (close to 10% of sales). Both drugs will ...

With GSK kicking its research and development engine into high gear in recent years, a shuffling of the scientific priorities ...

Government R&D encompasses all innovative work the government directly pays for, regardless of who does it.

Large cuts to government-funded research and development can endanger American innovation—and the vital productivity gains it supports.

A new Technology Alliance report warns that Washington’s innovation sector is at risk as public investment lags private R&D spending.

A new report on Michigan's innovation ecosystem found that Michigan leads among states with R&D investment, but falls behind in most other areas.

Investing.com -- GlaxoSmithKline plc (NYSE: GSK) shares gained 2.2% after the pharmaceutical giant reported first-quarter earnings and revenue that exceeded analyst estimates, driven by strong growth ...

The GSK complex at 14200 Shady Grove Road in Rockville was built in 2003.

Today’s R&D is over three percent with those investment shares switched. There’s certainly plenty of room for more federal action, though I would like more public and private investment.